Systematic Review of Genetic-Related Risk Factor and Inhibitor Epidemiology in People with Severe Hemophilia a from Africa: A 2023 Update
Tatiana Baglo, Alban Zohoun, Simon Azonbakin, Bienvenu Houssou, Romaric Massi, Charlotte Orou Guiwa, Ludovic Anani, Dorothée Kindé Gazard & Awa Omar Touré Fall · International Blood Research & Reviews · 2023
Background and Aims: Prevalence of factor VIII inhibitors in patients with hemophilia A varies from study to study, ranging from 15% to 30%. The important risk of inhibitor development is factor VIII mutation responsible for hemophilia A. Few studies have reported factor VIII mut...
Open access
Research Article
10.9734/ibrr/2023/v14i4324